AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

4DMEDICAL LTD

4.000

+0.2807.53%

Volume:23.93M

Turnover:95.02M

Market Cap:2.29B

PE:-28.57

High:4.090

Open:3.680

Low:3.630

Close:3.720

52wk High:5.420

52wk Low:0.225

Shares:572.19M

Float Shares:377.76M

Volume Ratio:6.67

T/O Rate:6.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.140

EPS(LYR):-0.140

ROE:-44.49%

ROA:-27.64%

PB:35.63

PE(LYR):-28.57

Loading ...

Overview Company News Filings

4DMedical (ASX:4DX) Valuation Check After Half Year Results And CT:VQ Growth Opportunity

Simply Wall St.

BRIEF-4DMedical Posts Half-Year Net Loss A$153.9 Million

4DMedical Fiscal H1 Loss Widens, Revenue Remains Flat; Withholds Dividend

MT Newswires Live

4DMedical Posts Fiscal H1 Loss of AU$0.259 Per Share, Revenue of AU$2.9 Million

MT Newswires Live

4DMedical Ltd - Hy Revenue From Ordinary Activities a$2.9 Mln

THOMSON REUTERS

4DMedical Ltd H1 Net Income AUD -153.9 Million

THOMSON REUTERS

How Expanded CT:VQ Roll-Out With UChicago Medicine Will Impact 4DMedical (ASX:4DX) Investors

Simply Wall St.

Assessing 4DMedical (ASX:4DX) Valuation After Expanded CT:VQ Partnership With University Of Chicago Medicine

Simply Wall St.

ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Stocks Struggle

MT Newswires Live

4DMedical Says Underlying Software-As-A-Service Revenue Jumps 31% YOY In Fiscal 2026 H1, Shares Climb 6%

MT Newswires Live

4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%

MT Newswires Live

4DMedical (ASX:4DX) Is Down 11.0% After A$79m CT:VQ™ Funding Round Has The Bull Case Changed?

Simply Wall St.

Cyclopharm Says Insurer Assumes Conduct of Defense Against 4DMedical Lawsuit In Victoria Supreme Court, Shares Jump 11%

MT Newswires Live

BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US

Assessing 4DMedical (ASX:4DX) Valuation After A$79.06 Million Follow On Equity Offering

Simply Wall St.

BRIEF-4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung Imaging

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and Increase Technology Dominance in Software-Based Lung Imaging

THOMSON REUTERS

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

ASX Biggest Losers

MT Newswires Live

4DMedical (ASX:4DX) Is Up 12.1% After A$150m Raise And Philips Deal Expansion Has The Bull Case Changed?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/4DX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"4DX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","market":"AU","secType":"STK","nameCN":"4DMEDICAL LTD","latestPrice":4,"timestamp":1772169120000,"preClose":3.72,"halted":0,"volume":23929475,"delay":0,"changeRate":0.07526881720430102,"nameEN":"4DMEDICAL LTD","floatShares":377762864,"shares":572191242,"eps":-0.14,"marketStatus":"Market Closed","change":0.28,"latestTime":"02-27 16:12:00 AEDT","open":3.68,"high":4.09,"low":3.63,"amount":95020069,"amplitude":0.123656,"askPrice":4,"askSize":62204,"bidPrice":3.8,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":-0.14,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1772406000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":3.72,"openAndCloseTimeList":[[1772146800000,1772168400000]],"volumeRatio":6.665393631112418,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"4DX.AU\",,,,,undefined,":{"symbol":"4DX.AU","floatShares":377762864,"roa":"-27.64%","roe":"-44.49%","lyrEps":-0.14,"volumeRatio":6.665393631112418,"shares":572191242,"dividePrice":0,"high":4.09,"amplitude":0.123656,"preClose":3.72,"low":3.63,"week52Low":0.225,"pbRate":"35.63","psRate":"391.01","week52High":5.42,"institutionHeld":0,"latestPrice":4,"committee":-0.949846,"eps":-0.14,"divideRate":0,"volume":23929475,"delay":0,"ttmEps":-0.14,"open":3.68,"prevYearClose":3.93,"prevWeekClose":3.88,"prevMonthClose":3.17,"prevQuarterClose":3.93,"fiveDayClose":3.88,"twentyDayClose":3.17,"sixtyDayClose":1.745},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/4DX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"4DX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"4DX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614813961","title":"4DMedical (ASX:4DX) Valuation Check After Half Year Results And CT:VQ Growth Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2614813961","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614813961?lang=en_us&edition=fundamental","pubTime":"2026-02-28 14:28","pubTimestamp":1772260090,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) is back in focus after its half-year results, where the company reported an improved adjusted net loss, a solid cash position, and highlighted its recently approved CT:VQ product.\nSee our latest analysis for 4DMedical.\nAt a latest share price of A$4.00, 4DMedical has seen a 12.68% 1 month share price return and a 133.92% 3 month share price return, while its 1 year total shareholder return is very large. This suggests momentum has been building around the CT:VQ rollout and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-valuation-check-after-half-year-results-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-valuation-check-after-half-year-results-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2614569009","title":"BRIEF-4DMedical Posts Half-Year Net Loss A$153.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614569009","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614569009?lang=en_us&edition=fundamental","pubTime":"2026-02-27 09:41","pubTimestamp":1772156478,"startTime":"0","endTime":"0","summary":"BRIEF-4DMedical Posts Half-Year Net Loss A$153.9 MillionFeb 27 (Reuters) - 4DMedical Ltd 4DX.AX:H1 NET INCOME AUD -153.9 MILLIONHY REVENUE FROM ORDINARY ACTIVITIES A$2.9 MILLIONFurther company coverage: 4DX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nPLXEA08DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2614320070","title":"4DMedical Fiscal H1 Loss Widens, Revenue Remains Flat; Withholds Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2614320070","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614320070?lang=en_us&edition=fundamental","pubTime":"2026-02-27 07:09","pubTimestamp":1772147391,"startTime":"0","endTime":"0","summary":"4DMedical  reported Friday fiscal first-half loss of AU$0.259 per share, widening from a loss of AU$0.025 a year earlier.Revenue for the six months ended Dec. 31, 2025, was AU$2.9 million, compared with AU$2.9 million a year earlier. Analysts surveyed by FactSet expected AU$3 million.The board continues to not recommend or declare a dividend.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2614072660","title":"4DMedical Posts Fiscal H1 Loss of AU$0.259 Per Share, Revenue of AU$2.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614072660","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614072660?lang=en_us&edition=fundamental","pubTime":"2026-02-27 06:13","pubTimestamp":1772143980,"startTime":"0","endTime":"0","summary":"4DMedical Posts Fiscal H1 Loss of AU$0.259 Per Share, Revenue of AU$2.9 Million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2614707122","title":"4DMedical Ltd - Hy Revenue From Ordinary Activities a$2.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614707122","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614707122?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:48","pubTimestamp":1772142532,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLXEA08DC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2614071292","title":"4DMedical Ltd H1 Net Income AUD -153.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2614071292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614071292?lang=en_us&edition=fundamental","pubTime":"2026-02-27 05:48","pubTimestamp":1772142532,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nPLXEA08DC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2609862590","title":"How Expanded CT:VQ Roll-Out With UChicago Medicine Will Impact 4DMedical (ASX:4DX) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2609862590","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609862590?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:15","pubTimestamp":1770380146,"startTime":"0","endTime":"0","summary":"In early February 2026, 4DMedical announced that its partnership with University of Chicago Medicine had been expanded to include commercial deployment of its CT:VQ lung imaging technology.\nThis move not only broadens real-world use of CT:VQ in a major academic hospital, but also underscores external confidence in 4DMedical’s commercial approach.\nWe’ll now examine how this expanded CT:VQ roll-out with University of Chicago Medicine shapes 4DMedical’s investment narrative and long-term...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/how-expanded-ctvq-roll-out-with-uchicago-medicine-will-impac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/how-expanded-ctvq-roll-out-with-uchicago-medicine-will-impac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4528","BK4587","ISBC","BK4588","BK4585","BK4551","4DX.AU","BK4211","BK4023","AI","BK4543","BK7094"],"gpt_icon":0},{"id":"2608367835","title":"Assessing 4DMedical (ASX:4DX) Valuation After Expanded CT:VQ Partnership With University Of Chicago Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2608367835","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608367835?lang=en_us&edition=fundamental","pubTime":"2026-02-04 18:22","pubTimestamp":1770200558,"startTime":"0","endTime":"0","summary":"Why 4DMedical Shares Are Back in Focus\n4DMedical (ASX:4DX) is back on investor radars after expanding its partnership with University of Chicago Medicine to include commercial deployment of its CT:VQ respiratory imaging technology.\nSee our latest analysis for 4DMedical.\nThe commercial CT:VQ rollout headlines a period where 4DMedical’s 90 day share price return of about 131% contrasts sharply with a 26% decline year to date, while its one year total shareholder return is very large at over...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-expanded-ctvq-par","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-expanded-ctvq-par","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2607396061","title":"ASX Midday Sector Update: Healthcare  Stocks Jump, Information Technology Stocks Struggle","url":"https://stock-news.laohu8.com/highlight/detail?id=2607396061","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607396061?lang=en_us&edition=fundamental","pubTime":"2026-01-30 10:35","pubTimestamp":1769740529,"startTime":"0","endTime":"0","summary":"Shares of healthcare firms jumped nearly 2% at midday Friday, amid a five-month hike in oil prices on escalating supply concerns.4DMedical  said its operating revenue for the fiscal first half came in at AU$2.9 million, with its underlying software-as-a-service revenue up 31% year-over-year.On the flip side, the information technology sector fell by over 1%.Spark New Zealand  completed the sale of a 75% stake in its data center division to Pacific Equity Partners.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4134","BK7094","BK4137","XBI","BK7042","BK4585","BK4588","III","LU0029874061.USD","SPK.AU","XLV","BK4581","HCSG","LU0128526141.USD","4DX.AU","LABU"],"gpt_icon":0},{"id":"2607065842","title":"4DMedical Says Underlying Software-As-A-Service Revenue Jumps 31% YOY In Fiscal 2026 H1, Shares Climb 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607065842","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607065842?lang=en_us&edition=fundamental","pubTime":"2026-01-30 09:13","pubTimestamp":1769735628,"startTime":"0","endTime":"0","summary":"4DMedical  said its operating revenue for the fiscal first half came in at AU$2.9 million, with its underlying software-as-a-service revenue up 31% year-over-year, according to a Friday Australian bourse filing.It expanded its existing distribution agreement with Koninklijke Philips, under which Philips will distribute CT:VQ, the firm's computed tomography-based ventilation-perfusion imaging technology, to healthcare systems across the US and Canada on full commercial terms.The agreement includes a mechanism wherein Philips underwrites the minimum order commitment of around AU$15 million in customer orders over 2026 and 2027.Its shares jumped 6% in recent trading on Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2607050428","title":"4DMedical Expands Agreement With University of Chicago Medicine to Include Commercial CT:VQ Deployment; Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607050428","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607050428?lang=en_us&edition=fundamental","pubTime":"2026-01-30 08:04","pubTimestamp":1769731492,"startTime":"0","endTime":"0","summary":"4DMedical (ASX:4DX) expanded its partnership with the University of Chicago Medicine to include commercial deployment of CT:VQ cardiothoracic imaging product, according to a Friday Australian bourse f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2606799784","title":"4DMedical (ASX:4DX) Is Down 11.0% After A$79m CT:VQ™ Funding Round Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606799784","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606799784?lang=en_us&edition=fundamental","pubTime":"2026-01-28 14:22","pubTimestamp":1769581322,"startTime":"0","endTime":"0","summary":"In mid-January 2026, 4DMedical Limited completed a follow-on equity offering of A$79.06 million, issuing 20,806,185 new ordinary shares at A$3.80 each, after holding a special call to explain the capital raise.\nThe company highlighted that the funds from this institutional placement will support the U.S. rollout of its CT:VQ™ lung imaging product, expand deployments in leading hospitals, and further its software-based respiratory imaging research efforts.\nWe will now examine how this...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-down-110-after-a79m-ctvq-funding-round-h","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-down-110-after-a79m-ctvq-funding-round-h","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","BK4543","BK7094","BK4551","BK4587","BK4585","AI","4DX.AU","BK4588","BK4528"],"gpt_icon":0},{"id":"2606275051","title":"Cyclopharm Says Insurer Assumes Conduct of Defense Against 4DMedical Lawsuit In Victoria Supreme Court, Shares Jump 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606275051","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606275051?lang=en_us&edition=fundamental","pubTime":"2026-01-27 10:15","pubTimestamp":1769480153,"startTime":"0","endTime":"0","summary":"Cyclopharm  confirmed that its insurer accepted indemnity regarding proceedings brought by 4DMedical  in the Supreme Court of Victoria against the firm and the insurer assumed conduct of the defense on Cyclopharm's behalf, according to a Tuesday Australian bourse filing.4DMedical sued the firm over allegedly misleading comments made during a March webinar, claiming the comment about its capital raising statements was false and misleading, and alleging that it caused damage to the company.Its shares jumped 11% in recent trading on Tuesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VCCTF","4DX.AU","BK7007","BK4095","CYC.AU","BK7094"],"gpt_icon":1},{"id":"2606426278","title":"BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2606426278","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606426278?lang=en_us&edition=fundamental","pubTime":"2026-01-27 09:14","pubTimestamp":1769476465,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Cyclopharm rises on med-tech clinical guideline win in US** Shares of Cyclopharm CYC.AX advance as much as 15.34% to A$1.015, their biggest intraday pct gain December 1, 2025** The ra","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nL6N3YS02L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","BK7094","CYC.AU","4DX.AU"],"gpt_icon":0},{"id":"2606820372","title":"Assessing 4DMedical (ASX:4DX) Valuation After A$79.06 Million Follow On Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2606820372","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606820372?lang=en_us&edition=fundamental","pubTime":"2026-01-27 08:43","pubTimestamp":1769474602,"startTime":"0","endTime":"0","summary":"Follow on equity offer puts 4DMedical in focus\n4DMedical (ASX:4DX) has drawn fresh investor attention after completing a follow on equity offering, raising A$79.06 million through the issue of more than 20,806,000 new ordinary shares at A$3.80 each.\nSee our latest analysis for 4DMedical.\nDespite the capital raise pricing the new shares at A$3.80, 4DMedical’s latest share price of A$4.05 sits above that level. The 90 day share price return is above 100% and the 1 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-a7906-million-fol","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/assessing-4dmedical-asx4dx-valuation-after-a7906-million-fol","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","EQR","BK4585","BK4588","BK4215","BK7094"],"gpt_icon":0},{"id":"2606422466","title":"BRIEF-4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2606422466","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606422466?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:53","pubTimestamp":1769468025,"startTime":"0","endTime":"0","summary":"BRIEF-4Dmedical Secures Us$100+ Million Funding To Accelerate U.S. Expansion And Increase Technology Dominance In Software-Based Lung ImagingJan 26 (Reuters) - 4DMedical Ltd 4DX.AX:4DMEDICAL SECURES U","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094"],"gpt_icon":0},{"id":"2606214492","title":"4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and Increase Technology Dominance in Software-Based Lung Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2606214492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606214492?lang=en_us&edition=fundamental","pubTime":"2026-01-27 06:28","pubTimestamp":1769466501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YR0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7094","4DX.AU"],"gpt_icon":0},{"id":"2604192537","title":"4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2604192537","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604192537?lang=en_us&edition=fundamental","pubTime":"2026-01-20 19:00","pubTimestamp":1768906800,"startTime":"0","endTime":"0","summary":"Funding will scale hospital deployments for groundbreaking CT:VQ imaging product, strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and moreLOS ANGELES and MELBOURNE, Australia, Jan. 20, 2026 /PRNewswire/ -- 4DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million  in new institutional placement. The investment will primarily be leveraged to accelerate U.S. adoption of its class-leading \"CT:VQ\" product and significantly boost research and development—bolstering 4D's technology lead in software-based lung imaging.Backed by new institutional funding, 4DMedical is advancing its respiratory imaging technology and expanding the U.S. rollout of its FDA-cleared CT:VQ software.Following the raise, 4DMedical reported a pro forma cash position exceeding US$130+ million , which will support the company's U.S. expansion strategy and growing installed base.Built to integrate into clini","market":"fut","thumbnail":"https://mma.prnewswire.com/media/2865006/4DMedical_Respiratory_Imaging.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2865006/4DMedical_Respiratory_Imaging.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/4dmedical-secures-us100-million-funding-to-accelerate-us-expansion-and-increase-technology-dominance-in-software-based-lung-imaging-302665063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["4DX.AU","BK7094","AAQC"],"gpt_icon":0},{"id":"2604163777","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2604163777","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604163777?lang=en_us&edition=fundamental","pubTime":"2026-01-20 11:51","pubTimestamp":1768881077,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Tuesday.ARB : -12%, AU$28.544DMedical : -9%, AU$4.39Dateline Resources : -7%, AU$0.36Lynas Rare Earths : -7%, AU$15.15Clarity Pharmaceuticals : -6%, AU$3.06Perenti : -6%, AU$2.82Vulcan Energy : -6%, AU$4.04Austal : -6%, AU$8.06Orora : -6%, AU$2.13Pmet Resources : -5%, AU$0.65","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7507","BK7051","BK7104","BK7115","BK7096","PRN.AU","BK7053","BK7095","ARB.AU","LYC.AU","CU6.AU","DTR.AU","VUL.AU","BK7504","ASB.AU","PMT.AU","ORA.AU","4DX.AU","BK7094"],"gpt_icon":0},{"id":"2604113287","title":"4DMedical (ASX:4DX) Is Up 12.1% After A$150m Raise And Philips Deal Expansion Has The Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113287","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604113287?lang=en_us&edition=fundamental","pubTime":"2026-01-19 19:11","pubTimestamp":1768821062,"startTime":"0","endTime":"0","summary":"4DMedical Limited recently completed a follow-on equity offering of A$79.06 million at A$3.80 per share, as part of a broader A$150 million capital raise to support commercialization of its CT:VQ lung imaging technology following FDA clearance.\nThe expanded distribution agreement with Philips, including a minimum US$10 million order commitment for 2026–2027 and growing use of CT:VQ in leading U.S. medical centers, points to a more intensive push into the North American market.\nNext, we’ll...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-up-121-after-a150m-raise-and-philips-dea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-4dx/4dmedical-shares/news/4dmedical-asx4dx-is-up-121-after-a150m-raise-and-philips-dea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["4DX.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":91,"code":"91000000","status":"200"}]}}